Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 0378-7316

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 0378-7316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (2bb5d4df 72a9 4f35 80c1 D3634327b14a 01)

Bar chart showing percentages of bleeding and/or spotting and bleeding alone during different cycles (1 to 4) for the drug kit Levonorgestrel and Ethinyl Estradiol. Each cycle is divided into days and sample sizes (N) are provided, with two categories represented: bleeding and/or spotting and bleeding only.*

FDA Label Image

Figure (2bb5d4df 72a9 4f35 80c1 D3634327b14a 04)

The image is a diagram illustrating pregnancy rates per 100 women per year associated with different contraceptive methods. It categorizes methods from fewer to more pregnancies, listing implants, injections, intrauterine devices, sterilization as having the fewest pregnancies; birth control pills, skin patch, vaginal rings with hormones next; followed by condoms and diaphragm; then no sex during fertile days, spermicide, withdrawal; and no birth control resulting in the most pregnancies.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure of levonorgestrel shown as a molecular diagram with labeled molecular formula C21H28O2 and molecular weight 312.4.*

FDA Label Image

Image 02

Chemical structure of ethinyl estradiol depicted with molecular formula C20H24O2 and molecular weight 296.4 shown below the diagram.*

FDA Label Image

Image 03

Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol 28-tablet kit by Mylan Pharmaceuticals Inc. The pack features a weekly calendar layout with circles for each day across four weeks (Sunday to Saturday), guiding daily tablet use. Strengths listed include 0.15 mg levonorgestrel and varying doses of ethinyl estradiol (0.002 mg to 0.03 mg).*

FDA Label Image

Image 04

Kit packaging label for Levonorgestrel and Ethinyl Estradiol tablets from Mylan Pharmaceuticals Inc., showing a calendar layout for weeks 5 through 8 with daily circular tablet indicators for Sunday through Saturday. The label lists strengths for the tablets as 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg, and 0.01 mg for levonorgestrel and ethinyl estradiol. The package contains 28 tablets.*

FDA Label Image

Image 05

A tablet blister pack insert showing a 4-week dosing calendar for weeks 9 to 12, with each week containing seven circular tablet markers labeled by day (Sunday to Saturday). The insert includes labeling for levonorgestrel and ethinyl estradiol tablets, USP, and ethinyl estradiol tablets USP with specific dosages noted, totaling 35 tablets.*

FDA Label Image

Image 06

Packaging label for Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets USP, a prescription drug kit by Mylan Pharmaceuticals. The label shows multiple tablet strengths: 0.15 mg / 0.02 mg, 0.15 mg / 0.025 mg, 0.15 mg / 0.03 mg, and 0.01 mg. The package contains one extended-cycle tablet blister pack with a total of 91 tablets. The design includes floral graphics and Mylan logos.*

FDA Label Image

Image 07

A forest plot chart depicting effect estimates from various studies comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use'. It lists study names and years on the left, plots point estimates with confidence intervals horizontally against an effect estimate scale from -1.50 to 2.00, and provides corresponding OR, RR, or HR values with confidence intervals on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.